Basilea Pharmaceutica AG
Basilea Pharmaceutica AG (BPMUF) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
bpmuf · market cap & enterprise value · FMP · as of Jun 5, 2026
Core market cap & key metrics
As of Jun 5, 2026, Basilea Pharmaceutica AG (BPMUF) has a market cap — also referred to as its net worth or valuation — of $805,588,844, making it one of the top most valuable companies globally. Market Cap = $65.10 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Basilea Pharmaceutica AG (BPMUF) has a market cap — also referred to as its net worth or valuation — of $805,588,844 as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Basilea Pharmaceutica AG reached its all-time high market cap of $819,531,283.25 on Dec 31, 2017. Comparing the Basilea Pharmaceutica AG market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Basilea Pharmaceutica AG net worth vs peers and ask how Basilea Pharmaceutica AG valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
BPMUF market cap · 6 questionsBasilea Pharmaceutica AG's net worth — measured as market capitalization — is $805,588,844 as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$65.10 (price) × shares outstanding.